Applications of quantitative 1H- and 13C-NMR spectroscopy in drug analysis.

[1]  K. Holme,et al.  Monitoring the purity of pharmaceutical heparin preparations by high-field 1H-nuclear magnetic resonance spectroscopy. , 1989, Journal of pharmaceutical sciences.

[2]  R. Rothchild,et al.  Quantitative NMR assay for aspirin, phenacetin, and caffeine mixtures with 1,3,5-trioxane as internal standard. , 1986, Journal of pharmaceutical and biomedical analysis.

[3]  C. Lau-cam,et al.  A Stability Indicating Proton NMR Spectroscopic Assay Method for Succinylcholine Chloride Injections , 1985 .

[4]  A. Casy,et al.  Studies of carbon‐13 n.m.r. spectroscopy in pharmaceutical analysis: the composition of commercial samples of gentamicin sulphate , 1983, The Journal of pharmacy and pharmacology.

[5]  George C. Levy,et al.  Software for quantitative analysis by carbon-13 Fourier transform nuclear magnetic resonance spectrometry , 1983 .

[6]  B. Giessen,et al.  Quantitative analysis of alkene/alkane mixtures by carbon-13 nuclear magnetic resonance spectrometry , 1982 .

[7]  D. Horton,et al.  Tautomeric equilibria of some sugars by partially relaxed, 13C pulse Fourier-transform, nuclear magnetic resonance spectroscopy , 1982 .

[8]  M. Imanari,et al.  Assay of Aspirin, Ethenzamide and Caffeine Mixture by 13C NMR Spectrometry , 1981 .

[9]  M. Tischler,et al.  Determination of dextro- and levomethorphan mixtures using chiral lanthanide NMR shift reagents. , 1980, Journal of pharmaceutical sciences.

[10]  J. Delpuech,et al.  Optimum conditions for nondestructive quantitative analysis by carbon-13 NMR , 1980 .

[11]  K. Yamasaki,et al.  Qualitative and Quantitative Analysis of Ephedra Alkaloids in Ephedrae Herba by Carbon-13 Nuclear Magnetic Resonance , 1979 .

[12]  D. Staiger,et al.  Quantitative determination of cephalexin in cephradine by NMR spectroscopy. , 1978, Journal of pharmaceutical sciences.

[13]  D. Calam,et al.  Control of the composition of gentamicin sulphate by proton magnetic resonance spectrometry , 1978, The Journal of pharmacy and pharmacology.

[14]  T. Mareci,et al.  Quantitative analysis of mixtures by carbon-13 nuclear magnetic resonance spectrometry , 1977 .

[15]  H. Avdovich,et al.  Application of proton and 13C-NMR spectroscopy to estimation of diastereoisomer ratio in phenethicillin. , 1977, Journal of pharmaceutical sciences.

[16]  I. Smith,et al.  Quantitative analysis of degradation products in pilocarpine hydrochloride ophthalmic formulations. , 1977, Journal of pharmaceutical sciences.

[17]  J. Shoolery.  Some quantitative applications of 13C NMR spectroscopy , 1977 .

[18]  D. Canet.  Systematic errors due to improper waiting times in heteronuclear overhauser effect measurements by the gated decoupling technique , 1976 .

[19]  J. Blunt,et al.  An automated procedure for qualitative and quantitative analysis of mixtures by means of carbon magnetic resonance spectroscopy: Applications to carbohydrate analysis , 1976 .

[20]  B. Thiault,et al.  Quantitative analysis by nuclear magnetic resonance with fourier transform II13C resonance , 1976 .

[21]  G. C. Levy,et al.  Quantitative carbon-13 Fourier transform nuclear magnetic resonance. Limitations of spin relaxation reagents , 1975 .

[22]  O. Yamamoto,et al.  Computer-aided quantitative analysis by proton magnetic resonance for compounds with complex spectra , 1975 .

[23]  R. Harrison,et al.  NMR determination of the enantiomer composition of penicillamine using an optically active europium shift reagent , 1974 .

[24]  Ray Freeman,et al.  Proton-decoupled NMR. Spectra of carbon-13 With the nuclear overhauser effect suppressed , 1972 .